SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $557 | -99.8% | 21,650 | +326.2% | 0.05% | +50.0% |
| Q1 2022 | $287,000 | -57.5% | 5,080 | -53.4% | 0.03% | -54.7% |
| Q4 2021 | $675,000 | +39.5% | 10,890 | +42.7% | 0.08% | +29.3% |
| Q3 2021 | $484,000 | +30.5% | 7,630 | +69.6% | 0.06% | +56.8% |
| Q2 2021 | $371,000 | – | 4,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $125,662 | 14.04% |
| Finepoint Capital LP | 643,000 | $16,724 | 5.41% |
| Boxer Capital, LLC | 3,421,541 | $88,994,281 | 4.69% |
| Deep Track Capital, LP | 3,109,886 | $80,888,135 | 3.40% |
| Artal Group S.A. | 2,000,000 | $52,020 | 2.90% |
| EcoR1 Capital, LLC | 3,460,208 | $90,000,010 | 2.74% |
| M28 Capital Management LP | 109,900 | $2,858,499 | 2.72% |
| Orbimed Advisors | 5,250,000 | $136,552,500 | 2.61% |
| Perceptive Advisors | 2,617,691 | $68,086,143 | 1.91% |
| SPHERA FUNDS MANAGEMENT LTD. | 316,625 | $8,235,416 | 1.77% |